SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-17-004377
Filing Date
2017-08-14
Accepted
2017-08-14 16:45:13
Documents
61
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q s107093_10q.htm 10-Q 648656
2 EXHIBIT 31.1 s107093_ex31-1.htm EX-31.1 8502
3 EXHIBIT 31.2 s107093_ex31-2.htm EX-31.2 8419
4 EXHIBIT 32.1 s107093_ex32-1.htm EX-32.1 5317
5 EXHIBIT 32.2 s107093_ex32-2.htm EX-32.2 5431
  Complete submission text file 0001615774-17-004377.txt   2923096

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nspx-20170630.xml EX-101.INS 486060
7 XBRL SCHEMA FILE nspx-20170630.xsd EX-101.SCH 32026
8 XBRL CALCULATION FILE nspx-20170630_cal.xml EX-101.CAL 36048
9 XBRL DEFINITION FILE nspx-20170630_def.xml EX-101.DEF 114197
10 XBRL LABEL FILE nspx-20170630_lab.xml EX-101.LAB 236118
11 XBRL PRESENTATION FILE nspx-20170630_pre.xml EX-101.PRE 197039
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 171030970
SIC: 2834 Pharmaceutical Preparations